Novartis Ringaskiddy to be sold to UK firm Sterling

Novartis Ireland employs 1,500 people across three locations in Cork and Dublin

Companies said the agreement with Sterling will secure the continued manufacturing of medicines and significant expertise in Ringaskiddy.

Pharmaceutical manufacturer Novartis has reached an agreement with UK firm Sterling Pharma Solutions to divest its facility in Ringaskiddy in Cork.

As part of the agreement announced today, Sterling will produce medicines in Ireland for Novartis. Both companies said the agreement with Sterling will secure the continued manufacturing of medicines and significant expertise in Ringaskiddy.